citalopram has been researched along with Cardiac Failure in 10 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether 24 months of treatment with escitalopram improves mortality, morbidity, and mood in patients with chronic systolic heart failure and depression." | 9.22 | Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial. ( Angermann, CE; Blankenberg, S; Böhm, M; Deckert, J; Edelmann, F; Ertl, G; Faller, H; Gelbrich, G; Gottwik, M; Graf, T; Gunold, H; Haass, M; Kindermann, I; Pankuweit, S; Prettin, C; Schunkert, H; Störk, S; Wachter, R, 2016) |
| "Citalopram treatment of MDD in older patients with heart failure is well-tolerated with low rates of side effects, but was not significantly more effective than placebo in the treatment of depression." | 9.14 | A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms. ( Alves, TC; Andrei, AM; da Silva Telles, RM; Fraguas, R; Iosifescu, DV; Rays, J; Wajngarten, M, 2009) |
| "To determine whether 24 months of treatment with escitalopram improves mortality, morbidity, and mood in patients with chronic systolic heart failure and depression." | 5.22 | Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial. ( Angermann, CE; Blankenberg, S; Böhm, M; Deckert, J; Edelmann, F; Ertl, G; Faller, H; Gelbrich, G; Gottwik, M; Graf, T; Gunold, H; Haass, M; Kindermann, I; Pankuweit, S; Prettin, C; Schunkert, H; Störk, S; Wachter, R, 2016) |
| "Citalopram treatment of MDD in older patients with heart failure is well-tolerated with low rates of side effects, but was not significantly more effective than placebo in the treatment of depression." | 5.14 | A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms. ( Alves, TC; Andrei, AM; da Silva Telles, RM; Fraguas, R; Iosifescu, DV; Rays, J; Wajngarten, M, 2009) |
| "MOOD-HF is a prospective, randomised, double-blind, placebo-controlled, 2-armed, parallel-group multicenter trial investigating the effects of the serotonin re-uptake inhibitor (SSRI) escitalopram on morbidity and mortality (primary endpoint), severity of depression, anxiety, cognitive function, quality of life and health care expenditure in 700 patients with symptomatic systolic CHF and major depression diagnosed by structured clinical interview." | 5.12 | Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). ( Angermann, CE; Deckert, J; Ertl, G; Faller, H; Fallgatter, A; Gelbrich, G; Störk, S, 2007) |
| " The patient was diagnosed with serotonin syndrome, attributed to the coadministration of 2 commonly prescribed medications (citalopram and omeprazole)." | 3.88 | Hyperpyrexia in a patient with a left ventricular assist device: a diagnosis beyond the obvious. ( Charitos, C; Kapelios, CJ; Tsamatsoulis, M, 2018) |
| " The case presentation illustrates the role of pregabalin in successful medical management of this chronic pain disorder, as well as the management of common psychiatric morbidities associated with this condition." | 3.74 | Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia. ( Jerome, L, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, M | 1 |
| Kwak, MJ | 1 |
| Aguilar, D | 1 |
| Goyal, P | 1 |
| Holmes, HM | 1 |
| Deshmukh, AA | 1 |
| Aparasu, RR | 1 |
| Tsamatsoulis, M | 1 |
| Kapelios, CJ | 1 |
| Charitos, C | 1 |
| Angermann, CE | 3 |
| Gelbrich, G | 2 |
| Störk, S | 2 |
| Gunold, H | 1 |
| Edelmann, F | 1 |
| Wachter, R | 1 |
| Schunkert, H | 1 |
| Graf, T | 1 |
| Kindermann, I | 1 |
| Haass, M | 1 |
| Blankenberg, S | 1 |
| Pankuweit, S | 1 |
| Prettin, C | 1 |
| Gottwik, M | 1 |
| Böhm, M | 1 |
| Faller, H | 2 |
| Deckert, J | 3 |
| Ertl, G | 3 |
| Ströhle, A | 1 |
| Rieckmann, N | 1 |
| Lekakis, J | 1 |
| Ikonomidis, I | 1 |
| Papoutsi, Z | 1 |
| Moutsatsou, P | 1 |
| Nikolaou, M | 1 |
| Parissis, J | 1 |
| Kremastinos, DT | 1 |
| Fraguas, R | 1 |
| da Silva Telles, RM | 1 |
| Alves, TC | 1 |
| Andrei, AM | 1 |
| Rays, J | 1 |
| Iosifescu, DV | 1 |
| Wajngarten, M | 1 |
| Labos, C | 1 |
| Dasgupta, K | 1 |
| Nedjar, H | 1 |
| Turecki, G | 1 |
| Rahme, E | 1 |
| Jerome, L | 1 |
| Fallgatter, A | 1 |
4 trials available for citalopram and Cardiac Failure
6 other studies available for citalopram and Cardiac Failure
| Article | Year |
|---|---|
Prescribing Trend of Inappropriate Medications in Outpatient Clinics for Older Adults With Heart Failure in the United States: NAMCS 2012 to 2016.
Topics: Aged; Ambulatory Care; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressi | 2021 |
Hyperpyrexia in a patient with a left ventricular assist device: a diagnosis beyond the obvious.
Topics: Aged; Citalopram; Fever; Heart Failure; Heart-Assist Devices; Humans; Male; Omeprazole; Proton Pump | 2018 |
Escitalopram and Outcomes Among Patients With Depression and Heart Failure.
Topics: Citalopram; Depression; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Heart | 2016 |
Escitalopram and Outcomes Among Patients With Depression and Heart Failure-Reply.
Topics: Citalopram; Depression; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Heart | 2016 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Ag | 2011 |
Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia.
Topics: Amitriptyline; Analgesics; Anti-Ulcer Agents; Anticoagulants; Antidepressive Agents; Anxiety; Cardio | 2007 |